CAS 1262992-43-7
:Rifaximin-d6
Description:
Rifaximin-d6 is a deuterated form of the antibiotic rifaximin, which is primarily used to treat gastrointestinal infections, particularly those caused by non-invasive strains of bacteria. As a derivative of rifaximin, Rifaximin-d6 retains similar pharmacological properties but is labeled with deuterium, which can be useful in research applications, particularly in pharmacokinetic studies and metabolic tracking. The presence of deuterium enhances the stability of the compound and can improve the accuracy of analytical methods such as mass spectrometry. Rifaximin itself is a broad-spectrum antibiotic that works by inhibiting bacterial RNA synthesis, making it effective against a variety of Gram-positive and Gram-negative bacteria. Rifaximin-d6 is typically utilized in scientific research rather than clinical applications, allowing for the investigation of drug metabolism and behavior in biological systems. Its chemical structure includes a complex bicyclic ring system, contributing to its mechanism of action and efficacy.
Formula:C43H51N3O11
Synonyms:- NZCRJKRKKOLAOJ-PLMIFOOKSA-N
- Rifaximin-d6 (Major)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Rifaximin-d6 (Major)
CAS:Controlled Product<p>Applications Non-absorbable semisynthetic Rifamycin antibiotic.<br>References Brufani, M., et al.: J. Antibiot., 37, 1611 (1984), Gillis, J.C., et al.: Drugs, 49, 467 (1995), Huang, D.B., et al.: J. Infection, 50, 97 (2005),<br></p>Formula:C43D6H45N3O11Color and Shape:OrangeMolecular weight:791.92Rifaximin-d6 (major)
CAS:Rifaximin-d6 is a peptide. It is an activator of ion channels and a ligand for receptors and ligands. Rifaximin-d6 has been shown to inhibit the activity of protein interactions and can be used as a research tool for studies in cell biology, pharmacology, and immunology. Rifaximin-d6 is a high purity product with CAS No. 1262992-43-7.Formula:C43H51N3O11Purity:Min. 95%Molecular weight:791.9 g/mol
